BR0103072A - Processo para a preparação de compostos de pirazolo[4,3-d] pirimidin-7-ona e seus intermediários - Google Patents

Processo para a preparação de compostos de pirazolo[4,3-d] pirimidin-7-ona e seus intermediários

Info

Publication number
BR0103072A
BR0103072A BR0103072-8A BR0103072A BR0103072A BR 0103072 A BR0103072 A BR 0103072A BR 0103072 A BR0103072 A BR 0103072A BR 0103072 A BR0103072 A BR 0103072A
Authority
BR
Brazil
Prior art keywords
compounds
preparation
pyrazolo
pyrimidin
intermediates
Prior art date
Application number
BR0103072-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Charlotte Moira Norfo Allerton
Christopher Gordon Barber
Keith Michael Devries
Laurence James Harris
Philip Charles Levett
Joanna Teresa Negri
David James Rawson
Albert Shaw Wood
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018660A external-priority patent/GB0018660D0/en
Priority claimed from GB0107526A external-priority patent/GB0107526D0/en
Priority claimed from GB0110251A external-priority patent/GB0110251D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of BR0103072A publication Critical patent/BR0103072A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0103072-8A 2000-07-28 2001-07-30 Processo para a preparação de compostos de pirazolo[4,3-d] pirimidin-7-ona e seus intermediários BR0103072A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0018660A GB0018660D0 (en) 2000-07-28 2000-07-28 Pharmaceutically active compounds
GB0107526A GB0107526D0 (en) 2001-03-26 2001-03-26 Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-one compounds and intermediates thereof
GB0110251A GB0110251D0 (en) 2001-04-26 2001-04-26 Process for the preparation of pyrazolo[4,4-d]Pyrimidin-7-one compounds and intermediates thereof

Publications (1)

Publication Number Publication Date
BR0103072A true BR0103072A (pt) 2002-04-09

Family

ID=27255823

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0103072-8A BR0103072A (pt) 2000-07-28 2001-07-30 Processo para a preparação de compostos de pirazolo[4,3-d] pirimidin-7-ona e seus intermediários

Country Status (17)

Country Link
EP (1) EP1176147A1 (enExample)
JP (1) JP2002105076A (enExample)
KR (1) KR20020010102A (enExample)
CN (1) CN1335317A (enExample)
AR (1) AR035650A1 (enExample)
AU (1) AU754962B2 (enExample)
BR (1) BR0103072A (enExample)
CA (1) CA2354175A1 (enExample)
CZ (1) CZ20012713A3 (enExample)
HK (1) HK1040715A1 (enExample)
HU (1) HUP0103075A3 (enExample)
IL (1) IL144516A0 (enExample)
IN (1) IN191315B (enExample)
MX (1) MXPA01007676A (enExample)
PL (1) PL348935A1 (enExample)
RU (1) RU2224759C2 (enExample)
YU (1) YU51701A (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6831074B2 (en) 2001-03-16 2004-12-14 Pfizer Inc Pharmaceutically active compounds
GB0106631D0 (en) * 2001-03-16 2001-05-09 Pfizer Ltd Pharmaceutically active compounds
DK1620437T3 (da) 2003-04-29 2009-08-24 Pfizer Ltd 5,7-diaminopyrazolo-4,3-d-pyrimidiner, der er anvendelige til behandling af hypertension
JP2006219373A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するピリジニルピラゾロピリミジノン誘導体
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
ES2317209T3 (es) 2004-04-07 2009-04-16 Pfizer Inc. Pirazolo(4,3-) pirimidinas.
ATE464289T1 (de) * 2005-11-16 2010-04-15 Hoffmann La Roche Neues verfahren zur herstellung von thoc
WO2007107733A1 (en) * 2006-03-17 2007-09-27 Cipla Limited Synthesis of 4-[1-(4-cyano phenyl)-(1,2,4-tr1azol-1-yl)methyl] benzonitrile and 4-[1-(1h-1,2,4-triazol-1-yl)methylene benzonitrile intermediate
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
US8183381B2 (en) 2007-07-19 2012-05-22 Metabolex Inc. N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
EP2483281B1 (en) 2009-10-01 2014-06-04 Cymabay Therapeutics, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
WO2011163090A1 (en) 2010-06-23 2011-12-29 Metabolex, Inc. Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
AU2017305392A1 (en) 2016-08-03 2019-02-21 Cymabay Therapeutics, Inc. Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2089971A (en) * 1937-08-17 Condensation products of
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
GB9822238D0 (en) * 1998-10-12 1998-12-09 Pfizer Ltd Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
NZ517324A (en) * 1999-10-11 2003-09-26 Pfizer 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-YL)- dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors

Also Published As

Publication number Publication date
AR035650A1 (es) 2004-06-23
IL144516A0 (en) 2002-05-23
YU51701A (sh) 2003-12-31
JP2002105076A (ja) 2002-04-10
CN1335317A (zh) 2002-02-13
MXPA01007676A (es) 2002-10-23
HK1040715A1 (zh) 2002-06-21
CZ20012713A3 (cs) 2002-04-17
AU754962B2 (en) 2002-11-28
KR20020010102A (ko) 2002-02-02
HU0103075D0 (en) 2001-10-28
HUP0103075A3 (en) 2003-04-28
CA2354175A1 (en) 2002-01-28
RU2224759C2 (ru) 2004-02-27
IN191315B (enExample) 2003-11-22
EP1176147A1 (en) 2002-01-30
HUP0103075A2 (hu) 2002-07-29
PL348935A1 (en) 2002-02-11
AU5767201A (en) 2002-01-31

Similar Documents

Publication Publication Date Title
BR0212185A (pt) Compostos e métodos para a preparação de compostos
BR0103072A (pt) Processo para a preparação de compostos de pirazolo[4,3-d] pirimidin-7-ona e seus intermediários
BR9811533A (pt) Produção de compostos avermectina
PT1249461E (pt) Catalisadores de amina bloqueados por acido para a producao de poliuretanos
BR0207302A (pt) Trifluorometilpurinas como inibidores da fosfodiesterase 4
EA200100757A1 (ru) Хинолинкарбоксамиды в качестве противовирусных агентов
BRPI0411268A (pt) processo para a preparação de um composto 3-aril butil-amina substituìdo
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BRPI0407282A (pt) Processo para preparação de inibidores de pirrolotriazina cinase
BR9808854A (pt) Processo para preparação de um composto, e, composto
ES2183340T3 (es) Procedimiento para la preparcion de compuestos de 4-bromometil-bifenilo.
MY117789A (en) Pyrroloquinolones as antiviral agents
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BR9911250A (pt) Processo para preparação de compostos
BR0004787A (pt) Processo para a preparação de compostos pirazolo[4,3-d] pirimidin-7-onas-3-piridilsulfonila bem como intermediários dos mesmos
GR1003795B (el) Μεθοδος παρασκευης της σιταλοπραμης.
BR9912870A (pt) Processo para sìntese de derivados de (1h) - benzo (c)quinolizina-3-onas
BR0007982A (pt) Processo para a preparação de um composto, e,composto
AR028740A1 (es) Procedimiento para la preparacion de pirazolopirimidinonas
BR0009453A (pt) Processo para a preparação de um composto
PT98518A (pt) Processo para a preparacao de 4-amino-delta-4-esteroides com accao inibidora da5alfa-redutase
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
DE60305003D1 (de) Verfahren zur herstellung von synergistischen stabilisatorgemischen
BR0210512A (pt) Processo de decomposição papa o ácido (r)-(-)-2-hidroxi-2-(2-clorofenil) acético
BRPI0400141A (pt) Composição de incenso inseticida, e emulsão e processo para produção da mesma

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.